Back
Aligos Therapeutics Stock Price Chart
Sponsored
ALGS
Sponsored
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
44
ALGS
Aligos Therapeutics
Last Price:
$34.15
Seasonality Move:
-27%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
The current trend is relatively stagnant and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aligos Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.37 | Sell |
20-day SMA: | 37.9 | Sell |
50-day SMA: | 28.75 | Buy |
200-day SMA: | 17.48 | Buy |
8-day EMA: | 34.42 | Sell |
20-day EMA: | 35.21 | Sell |
50-day EMA: | 29.79 | Buy |
200-day EMA: | 20.62 | Buy |
Aligos Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.91 | Buy |
Relative Strength Index (14 RSI): | 50.11 | Buy |
Chaikin Money Flow: | 205786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.96 - 41.26) | Sell |
Bollinger Bands (100): | (7.59 - 31.23) | Buy |
Aligos Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 34.24 while ALGS 8-day simple moving average is 34.37, which is a Sell signal.
-
The stock price of ALGS is 34.24 while Aligos Therapeutics 20-day SMA is 37.90, which makes it a Sell.
-
Aligos Therapeutics 50-day simple moving average is 28.75 while ALGS share price is 34.24, making it a Buy technically.
-
ALGS stock price is 34.24 and Aligos Therapeutics 200-day simple moving average is 17.48, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
44
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a SellThe current Aligos Therapeutics [ALGS] share price is $34.24. The Score for ALGS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
122.8M
Price in USD:
34.24
Share Volume:
221.4K
Aligos Therapeutics 52-Week Range
52-Week High:
46.80
52-Week Low:
6.76
Sell
44
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 34.24 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 34.24 while ALGS 8-day exponential moving average is 34.42, which is a Sell signal.
-
The stock price of ALGS is 34.24 while Aligos Therapeutics 20-day EMA is 35.21, which makes it a Sell.
-
Aligos Therapeutics 50-day exponential moving average is 29.79 while ALGS share price is 34.24, making it a Buy technically.
-
ALGS stock price is 34.24 and Aligos Therapeutics 200-day simple moving average is 20.62, creating a Buy signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 0.91, suggesting Aligos Therapeutics is a Buy
-
Aligos Therapeutics Relative Strength Index (RSI) is 50.11, which suggest Aligos Therapeutics is overbought
-
The Bollinger Bands (25) for Aligos Therapeutics is (32.96 - 41.26), which suggest Aligos Therapeutics is a Buy
-
The Bollinger Bands (100) for Aligos Therapeutics is (7.59 - 31.23), which suggest Aligos Therapeutics is a Buy
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.